Background: Medicinal plants are an important source of novel antimicrobial agents. Ayurvedic treatment involves the use of a variety of medicinal plants that merit investigation. Aims: To investigate the antimicrobial activity of bark of Pongamia pinnata (L.) Pierre, stem of Rubia cordifolia Linn, leaves of Jasminum officinale Linn, stem of Berberis ceylanica C.K. Schneid. and fruit of Garcina zeylanica Roxb. Subjects and Methods: Aqueous and ethanolic extracts of dried bark of Pongamia pinnata (Magul karanda), dried stem of Rubia cordifolia Linn (Welmadata), tender leaves of Jasminum officinale Linn (Jasmine) and dried stem of Berberis ceylanica (Dāruharidrā) were prepared according to standard protocols and tested for antimicrobial activity against five clinical isolates and one standard strain each of Candida albicans (ATCC 10231), Candida parapsilosis (ATCC 22019) and six Methicillin Resistant Staphylococcus aureus (MRSA) clinical isolates using the well diffusion method. Experiments were done in triplicates using well diffusion method. The plant extracts which gave a zone of inhibition in the well diffusion assay were further tested for Minimum Inhibitory Concentrations (MIC). Results: Aqueous and ethanolic extracts of Berberis ceylanica and ethanolic extract of Rubia cordifolia had antimicrobial activity against Candida albicans and Candida parapsilosis. Aqueous and ethanolic extracts of Garcinia zeylanica, and the ethanolic extracts of Jasminum officinale, Rubia cordifolia and Pongamia pinnata had antimicrobial activity against MRSA. Conclusions: Berberis ceylanica and Rubia crodifolia had antimicrobial activity against Candida species while Garcinia zeylanica, Jasminum officinale, Rubia crodifolia and Pongamia pinnata had antimicrobial activity against MRSA.
Introduction
Nearly 2000 to 2500 species of Sri Lankan flora are being used in the Ayurvedic practices in Sri Lanka. [1] Studies on medicinal plants used in ayurvedic or traditional treatment have demonstrated their potential as antimicrobials. [2] Phytochemicals obtained from medicinal plants have been used widely in the development of novel therapeutic agents including antimicrobial agents. The antimicrobial activity of several medicinal herbs used in traditional and ayurvedic medicine in Sri Lanka have been reported.
Multidrug resistant microbes pose a major challenge in health care and therefore the demand for alternative antimicrobials are increasing. WHO reports that more than one quarter of Staphylococcus aureus infections are due to methicillin resistant Staphylococcus aureus (MRSA). [3] MRSA is emerging as an important nosocomial pathogen which can cause mild superficial skin infections to severe life threatening systemic infections among hospitalized patients and treatment is difficult due to β-lactam resistance. [3] MRSA is becoming one of the common nosocomial pathogens in Sri Lanka, creating a major challenge for clinicians and a heavy economic burden to the health sector. [4] Candidiasis is the most common fungal infection in the world and may lead to superficial fungal infections or life threatening invasive infections. [5] Recently, antifungal resistance of Candida species has been increasingly reported requiring more potent antifungal agents.
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Preparation of hot water extract
Raw materials were rinsed, dried and aqueous extract was prepared using 60 g of dried plant material (P. pinnata, R. cordifolia, B. ceylanica) and 120 g of fresh plant material (J. officinale) in 1440 ml water. This was boiled under low heat to reduce the volume to 240 ml according to Ayurvedic protocol. [6] The plant extracts were filtered using sterile Whatman No 1 large filter paper. Each filtrate was transferred to a sterile glass container and stored in refrigerator [4ºC] up to 2 weeks.
Preparation of ethanol extracts
Plant materials (60 g from each palnt) were refluxed separately with ethanol (1440 ml) for 4 h, filtered using a Whatman No 1 filter paper and evaporated to get the final volume of 240 ml under reduced pressure at 50 o C. [3] Each filtrate was transferred to a sterile glass container and stored at 4 o C up to two weeks.
Microorganisms
Five clinical isolates each of C. albicans, C. parapsilosis and two type strains of Candida species; C. albicans ATCC 10231, C. parapsilosis ATCC 22019, and six clinical isolates of Methicillin Resistant Staphylococcus aureus (MRSA) were obtained from the Department of Microbiology, Faculty of Medical Sciences, University of Sri Jayewardenepura. The methicillin resistant Staphylococcus aureus isolates were confirmed using Antibiotic sensitivity testing following the CLSI standards.
Well diffusion assay
Overnight cultures of Candida spp. and MRSA were used to make suspensions (0.5 Mac Farland) and spread on the surface of Mueller Hinton Agar (MHA) plates. Wells were cut using a 9 mm sterile cork borer. The bottom of the wells was sealed by adding a drop of molten agar. Ethanolic plant extracts were dissolved in Dimethyl sulfoxide (DMSO) (Sigma Aldrich) and brought to final (neat) concentration. Then 200µl of the aqueous or ethanolic plant extracts were loaded into the wells using micropipette. Fluconazole and Amphotericin B (0.05 mg/ml) were used as positive controls against Candida strains and Cloxacillin (Karnataka Antibiotics and Pharmaceuticals Limited) and Vancomycin (Karnataka Antibiotics and Pharmaceuticals Limited) (30 mg/ml) of IV antibacterial preparations were used as positive control against MRSA strains.
The inhibitory zone of microbial growth around the well was called as the zone of inhibition (ZOI), this was calculated by subtracting the measured diameter of the ZOI from the well diameter in aqeous extracts, and for the ethanolic extracts the ZOI was obtained by subtracting the diameter of ZOI from the DMSO control well ZOI. In the well diffusion assay any zone of inhibition observed was considered as significant. We included a cloxacillin containing well which shows no zone of inhibition as a negative control.
Well diffusion assay was done in triplicates for each individual isolate and average zone of inhibition was calculated.
Minimum inhibitory concentration
Minimum Inhibitory Concentration (MIC) was determined using the pour plate method as described previously. [7] Both aqueous and ethanolic extracts were prepared using 60 g of dried plant material and 120 g of fresh plant material boiled down from 1440 ml to 240 ml. Briefly, doubling dilutions of extracts (Neat, 1/2, 1/4, 1/8, 1/16, 1/32, 1/64) were prepared in MHA using the aqueous extracts and ethanolic extracts. Molten MHA (20 ml) was cooled to 50 o C, mixed well with each extract dilution and poured into sterile petri plates. The plates were allowed to dry and a grid containing 12 squares were drawn on the back of the glass plate. Five microliters of each organism suspension (prepared to the 0.5 Mac Farland standard) were placed on the surface of the agar plate in each grid. The drop was allowed to stand for few minutes and the plate was incubated in the upright position at 37 o C. Presence or absence of any growth of the organism was observed after 24 hours. The lowest concentration of the extract that inhibited the visible growth of a microorganism after overnight incubation was determined as MIC. Experiment was done in triplicates and the average MIC was calculated.
Results
The aqueous extracts (250 mg/ml) of B. ceylanica, inhibited the clinical isolates of C. albicans (ZOI = 4.5 mm), while in the ethanolic extracts, both C. albicans ATCC 10231 (ZOI = 14 mm) and the C. albicans clinical isolates (ZOI = 15.8 mm) showed inhibition. Aqueous extract of B. ceylanica had a ZOI of 3 mm against Candida parapsilosis ATCC 22019 while a larger ZOI (13.7 mm) was obtained for the ethanolic extracts against the type strain and clinical isolates of C. parapsilosis [ Table 1 ].
Aqueous extract of G. zeylanica exhibited antibacterial activity against MRSA with a ZOI of 4 mm. Dried stem of R. cordifolia gave a ZOI for two of the isolates but was resistant to the others. Zones of inhibition was observed with the ethanolic extracts of P. pinnata (4 mm), R.cordifolia (10.7 mm), J. officinale (4.6 mm) and G. zeylanica (14.2 mm) against MRSA [ Table 1 ].
The results of the well diffusion assay showed sensitivity of C. albicans against aqueous extracts of B. ceylanica and the ethanolic extract of R. cordifolia while the MRSA strains were inhibited by aqueous and ethanolic extracts of G. zeylanica, ethanolic extracts of P. pinnata and J. Officinale [ Figure 1 ].
Therefore, these extracts were further tested to determine their minimum inhibitory concentration against the isolates. The MIC of aqueous extract of B. ceylanica against C. albicans and MIC of aqueous extract of G. zeylanica against MRSA was at neat concentration. Both extracts were prepared according to the standard method described in Ayurvedic texts. The ethanolic extracts had a MIC of 1/8 dilution for R. cordifolia against C. albicans, while the MICs of ethanolic extracts of P. pinnata, J. officinale and G. zeylanica against MRSA was at the dilutions of 1/8, 1/16 and 1/16 respectively.
Discussion
In this study, G. zeylanica exhibited an antibacterial activity against methicillin resistant Staphylococcus aureus (MRSA). This is the first study to our knowledge which has investigated the antimicrobial activity of this plant. The pericarp of G. zeylanica is used as a spice in Sri Lanka.
It is an endemic plant with no reported studies on its antimicrobial activity.
MRSA is increasingly responsible for causing nosocomial infections, particularly in critically ill patients. Methicillin resistant Staphylococcus aureus show resistance to all β-lactam antibiotics, and is often resistant to antibiotics such as macrolides and aminoglycosides, thus being multi drug resistant. [8] According to a study conducted in Sri Lanka, MRSA was isolated from 12.9% patients on admission to a surgical unit in National Hospital, Sri Lanka, while 6% were nosocomially infected during the hospital stay. [9] It is also important to note that G.gummi-gutta which belong to the same genus Garcinia has antibacterial activity against S. aureus. Garcinia gummi-gutta is used for treatment of skin related diseases in Ayurvedic medicines in Sri Lanka.
Aqueous extracts of B. ceylanica, had exhibited an inhibitory activity against isolates of C. albicans. Candida albicans have been reported to be a major pathogen responsible for human Candidiosis. However, recently non-albicans Candida species such as Candida parapsilosis, Candida glabrata, Candida tropicalis and Candida dubliniesis have been frequently identified as both pathogens and commensals. Further the incidence of C. parapsilosis infections has increased in the past few decades and is reported as the second most frequently isolated Candida spp from blood cultures. [5] Prophylactic and empirical use of antibiotics and antifungals are an important factor contributing to the development of antimicrobial resistance among these pathogens.
In Sri Lanka B. ceylanica is used in Ayurveda medicine to treat variety of infections. However, no studies have been reported on the antimicrobial activity of B. ceylanica against these two pathogens to the best of our knowledge. In Ayurveda, B. aristata is used to treat trachoma, skin diseases and diarrhea in India. Therapeutic properties of B. ceylanica are very rarely validated except the effects of Vipadikahara Grita Taila in which B. ceylanica is a major ingredient.
[10] The physico-chemical parameters, phytochemicals and some of the therapeutic properties are similar among both B. aristata and B. ceylanica. [11] In general, plants which have antimicrobioal properties exhibit wound healing properties. Similarly, J. officinale, [12] P. pinnata [13] and R. cordifolia [14] have shown wound healing properties in animal models.
Conclusion
Antimicrobial activity of two endemic plants G. zeylanica and B.ceylanica against MRSA and two Candida spp is reported for the first time in Sri Lanka. It is therefore important to investigate the potential of these plants as novel antimicrobial agents, targeting the multidrug resistant bacteria and fungi of clinical importance.
